Chavanet P, Atale A, Mahy S, Neuwirth C, Varon E, Dabernat H, Portier H
Département d'infectiologie, CHU de Dijon, BP 77908, 21000 Dijon, France.
Med Mal Infect. 2011 Jun;41(6):307-17. doi: 10.1016/j.medmal.2011.02.001. Epub 2011 Mar 22.
The aim of this study was to investigate the nasal carriage of Streptococcus pneumoniae (SP) and Haemophilus influenzae (HI) in children.
Nasal samples were swabbed from children 3 months to 3 years of age, between December 2006 and April 2007, in 10 day-care centers in Dijon.
Three hundred and eighty-five children, 22.7 ± 8.4 months, were included. All were vaccinated against H1 and 92% had received at least one dose of PCV7 vaccine. HI colonization (55%) was associated with young age and concomitant pneumococcal carriage (52.4% vs. 39%). Amoxicillin/clavulanate and cefotaxime resistance rates were 17% and 0.5%. Pneumococcal carriage (48%) was increased in case of prior hospitalization. The rate of PDSP, 50%, was increased in case of recent infection (91% vs. 81%), previous antibiotherapy (64% vs. 41%), and decreased if PCV7 was completed (40.2% vs. 61,8%). There was no resistance to amoxicillin. The erythromycin resistance rate was 50.5%. 15% of the strains were vaccinal serotypes. Thirty-six and 41% of the strains were related and non-related to vaccine serotypes. Twenty-four and 11.6% of the strains were serotypes 19A and 6A respectively.
Over the last 10 years the global antibiotic resistance in children decreased for SP (22.9%) but nasal colonization remained stable due to the increase of some serotypes, such as 19A, most often resistant to antibiotics. The vaccine effectiveness against HI is optimal since no HIb serotypes were detected; resistance to betalactam is currently due equally to enzymatic mechanism and alteration of protein binding penicillin.
本研究旨在调查儿童肺炎链球菌(SP)和流感嗜血杆菌(HI)的鼻腔携带情况。
2006年12月至2007年4月期间,在第戎的10所日托中心对3个月至3岁的儿童进行鼻腔样本擦拭。
纳入了385名儿童,年龄为22.7±8.4个月。所有儿童均接种了H1疫苗,92%的儿童至少接种了一剂PCV7疫苗。HI定植(55%)与年龄小和同时携带肺炎球菌(52.4%对39%)有关。阿莫西林/克拉维酸和头孢噻肟的耐药率分别为17%和0.5%。既往住院的儿童肺炎球菌携带率(48%)增加。近期感染(91%对81%)、既往抗生素治疗(64%对41%)时,侵袭性肺炎球菌疾病(PDSP)发生率(50%)增加,若完成PCV7接种则发生率降低(40.2%对61.8%)。对阿莫西林无耐药性。红霉素耐药率为50.5%。15%的菌株为疫苗血清型。36%和41%的菌株与疫苗血清型相关和不相关。24%和11.6%的菌株分别为19A和6A血清型。
在过去10年中,儿童中SP的全球抗生素耐药性有所下降(22.9%),但由于某些血清型(如最常对抗生素耐药的19A)增加,鼻腔定植情况保持稳定。由于未检测到HIb血清型,疫苗对HI的有效性最佳;目前对β-内酰胺类的耐药同样归因于酶促机制和青霉素结合蛋白的改变。